Literature DB >> 9853183

Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction.

M Vaage-Nilsen1, V Rasmussen, J F Hansen, L Hagerup, M B Sørensen, O Pedersen-Bjergaard, K Mellemgaard, N H Holländer, I Nielsen, B M Sigurd.   

Abstract

BACKGROUND: Ventricular ectopy early after an acute myocardial infarction (AMI) has previously been demonstrated to predict mortality. Less information is available about the prognostic implications of ventricular ectopy occurring late after an AMI, and no information is available about the prognostic implication of the development of ventricular ectopy during the first year after an AMI. HYPOTHESIS: The purpose of the present prospectively conducted trial, a part of the Danish Verapamil Infarction Trial II (DAVIT II), was to evaluate the prognostic implication of (1) ventricular premature complexes (VPCs) recorded by 24-h Holter monitoring 1 week, 1 month, and 16 months after an AMI; and (2) development of > 10 VPCs/h or of any complex ventricular ectopy, that is, pairs, more than two types of VPCs, ventricular tachycardia, or > 10 VPCs/h during follow-up after an AMI.
METHODS: Patients were monitored 1 week (n = 250), 1 month (n = 210), and 16 months (n = 201) after AMI.
RESULTS: Multivariate analyses based on history, clinical findings, and ventricular ectopy showed the following results: After 1 week, > 10 VPCs/h (p = 0.0006) and heart failure (p < 0.007); after 1 month, > 10 VPCs/h (p = 0.003) and resting heart rate (p < 0.02); and after 16 months, ventricular tachycardia (p = 0.002) independently predicted long-term mortality. Mortality was significantly predicted by the development of > 10 VPCs/h from 1 week to 1 month (p = 0.003) and 16 months (p = 0.03), and from 1 to 16 months (p = 0.007) after AMI, as well as by the development of any complex ventricular ectopy from 1 week to 1 month (p = 0.02) and 16 months (p = 0.01), and from 1 to 16 months (p = 0.04) after AMI.
CONCLUSION: The present study demonstrated that 1 week and 1 month after an AMI the quantity of VPCs, that is, > 10 VPCs/h, predicted mortality, whereas 16 months after an AMI the quality of VPCs, that is, ventricular tachycardia, predicted mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9853183      PMCID: PMC6655913          DOI: 10.1002/clc.4960211209

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.

Authors:  Xianqing Hu; Jian Cheng; Chunjian Li
Journal:  Eur J Clin Pharmacol       Date:  2017-09-30       Impact factor: 2.953

2.  Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording.

Authors:  Alexander Berkowitsch; Wojciech Zareba; Thomas Neumann; Ali Erdogan; Scott Mc Nitt; Arthur J Moss; Heinz F Pitschner
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

3.  Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.

Authors:  Sukardi Suba; Kirsten E Fleischmann; Hildy Schell-Chaple; Priya Prasad; Gregory M Marcus; Xiao Hu; Michele M Pelter
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.